pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

34,476 catalysts · 14,560 approval · 5,000 device 510k · 4,728 grant · 3,397 8k filing · 2,000 device pma · 2,000 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 17 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2005-12-06×clear all
type
  • approval14,560
  • device 510k5,000
  • grant4,728
  • 8k filing3,397
  • device pma2,000
  • device recall2,000
recall
1,126
  • device adverse event1,000
  • earnings584
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Dec 5, 2005

    8
    ›Dec 6, 2005approval7561d agoDEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Dec 6, 2005approval7561d agoENLON-PLUS (ATROPINE SULFATE) — FDA approvalAccord Healthcare Inc

    Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 6, 2005approval7561d agoENLON-PLUS (ATROPINE SULFATE) — FDA approvalAccord Healthcare Inc

    Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 6, 2005approval7561d agoLIDOCAINE HYDROCHLORIDE — FDA approvalLaryng-O-Jet

    Sponsor: COSETTE. Form: JELLY. Route: TOPICAL

    full page →Laryng-O-Jet →fda approvals ↗
    ›Dec 7, 2005approval7560d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

    Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Dec 9, 2005approval7558d agoZOVIRAX (ACYCLOVIR) — FDA approvalApotex Corp

    Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2005approval7558d agoZOVIRAX (ACYCLOVIR) — FDA approvalApotex Corp

    Sponsor: PHARMOBEDIENT. Form: SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2005approval7558d agoZOVIRAX (ACYCLOVIR) — FDA approvalApotex Corp

    Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗

    Week of Dec 12, 2005

    6
    ›Dec 14, 2005approval7553d agoSEVOFLURANE — FDA approvalSEVOFLURANE

    Sponsor: BAXTER HLTHCARE. Form: LIQUID. Route: INHALATION

    full page →SEVOFLURANE →fda approvals ↗
    ›Dec 16, 2005approval

    Week of Dec 19, 2005

    2
    ›Dec 21, 2005approval7546d agoFOSAMAX (ALENDRONATE SODIUM) — FDA approvalALENDRONATE SODIUM

    Sponsor: ORGANON. Form: TABLET. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›Dec 23, 2005approval

    Week of Dec 26, 2005

    4
    ›Dec 28, 2005approval7539d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Dec 28, 2005approval

    Week of Jan 2, 2006

    1
    ›Jan 6, 2006approval7530d agoALEVE (NAPROXEN SODIUM) — FDA approvalNAPROXEN SODIUM

    Sponsor: BAYER. Form: TABLET. Route: ORAL

    full page →NAPROXEN SODIUM →fda approvals ↗

    Week of Jan 9, 2006

    3
    ›Jan 11, 2006approval7525d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 11, 2006approval

    Week of Jan 16, 2006

    6
    ›Jan 17, 2006approval7519d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Jan 18, 2006approval

    Week of Jan 23, 2006

    2
    ›Jan 24, 2006approval7512d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2006approval

    Week of Jan 30, 2006

    2
    ›Jan 31, 2006approval7505d agoPROMETHAZINE WITH CODEINE (CODEINE PHOSPHATE) — FDA approvalCosette Pharmaceuticals Inc

    Sponsor: PHARM ASSOC. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›Feb 1, 2006approval

    Week of Feb 6, 2006

    2
    ›Feb 6, 2006approval7499d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA USA. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Feb 7, 2006approval

    Week of Feb 13, 2006

    11
    ›Feb 16, 2006approval7489d agoZYPREXA ZYDIS (OLANZAPINE) — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →fda approvals ↗
    ›Feb 16, 2006approval

    Week of Feb 20, 2006

    3
    ›Feb 22, 2006approval7483d agoKINERET (ANAKINRA) — FDA approvalSobi Inc

    Sponsor: BIOVITRUM AB. Form: VIAL. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Feb 23, 2006approval
    ← prev
    page 1 of 690
    next →
    7551d ago
    CLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 16, 2005approval7551d agoTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalAurobindo Pharma Ltd

    Sponsor: SUN PHARM INDS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 18, 2005approval7549d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

    Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 18, 2005approval7549d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

    Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Dec 18, 2005approval7549d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

    Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    7544d ago
    GABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    7539d ago
    METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Dec 29, 2005approval7538d agoCABERGOLINE — FDA approvalCABERGOLINE

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →CABERGOLINE →fda approvals ↗
    ›Dec 30, 2005approval7537d agoOXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: MIKART. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    7525d ago
    DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 11, 2006approval7525d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    7518d ago
    PONSTEL (MEFENAMIC ACID) — FDA approvalAvion Pharmaceuticals LLC

    Sponsor: AVION PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 19, 2006approval7517d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Jan 19, 2006approval7517d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Jan 19, 2006approval7517d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Jan 20, 2006approval7516d agoMEN'S ROGAINE (MINOXIDIL) — FDA approvalVeradermics, Inc

    Sponsor: KENVUE BRANDS. Form: AEROSOL, FOAM. Route: TOPICAL

    full page →fda approvals ↗
    7512d ago
    ENBREL (ETANERCEPT) — FDA approvalAMGEN INC

    Sponsor: IMMUNEX. Form: SYRINGE

    full page →fda approvals ↗
    7504d ago
    IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalSUMATRIPTAN SUCCINATE

    Sponsor: GLAXOSMITHKLINE. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
    7498d ago
    ENBREL (ETANERCEPT) — FDA approvalAMGEN INC

    Sponsor: IMMUNEX. Form: SYRINGE

    full page →fda approvals ↗
    7489d ago
    ZYPREXA ZYDIS (OLANZAPINE) — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →fda approvals ↗
    ›Feb 16, 2006approval7489d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 16, 2006approval7489d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 16, 2006approval7489d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Feb 16, 2006approval7489d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Feb 16, 2006approval7489d agoENBREL (ETANERCEPT) — FDA approvalAMGEN INC

    Sponsor: IMMUNEX. Form: SYRINGE

    full page →fda approvals ↗
    ›Feb 16, 2006approval7489d agoLUPRON DEPOT-PED KIT (LEUPROLIDE ACETATE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Feb 17, 2006approval7488d agoNAPROXEN SODIUM — FDA approvalNAPROXEN SODIUM

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →NAPROXEN SODIUM →fda approvals ↗
    ›Feb 17, 2006approval7488d agoPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE (CODEINE PHOSPHATE) — FDA approvalPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE

    Sponsor: HIKMA. Form: SYRUP. Route: ORAL

    full page →PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE →fda approvals ↗
    ›Feb 19, 2006approval7486d agoMETADATE CD (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE CD

    Sponsor: AYTU BIOPHARMA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →METADATE CD →fda approvals ↗
    7482d ago
    ZYPREXA ZYDIS (OLANZAPINE) — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2006approval7482d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    $ABBV257.95+3.04%
    $ABBV257.95+3.04%
    $OGN13.67-0.22%
    $RDY12.18+0.58%
    $ABBV257.95+3.04%
    $ABBV257.95+3.04%
    $MANE111.36+2.90%
    $AMGN426.25+1.64%
    $RDY12.18+0.58%
    $TEVA36.83+1.01%
    $AMGN426.25+1.64%
    $TEVA36.83+1.01%
    $TEVA36.83+1.01%
    $TEVA36.83+1.01%
    $TEVA36.83+1.01%
    $AMGN426.25+1.64%
    $RDY12.18+0.58%
    $AYTU2.2300-0.89%
    $AMRX18.18-1.33%